pre-seed
Stage
1
Investors
About
Noscendo GmbH develops DISQVER, a CE- and IVDR-marked diagnostic software platform that provides clinical diagnostics and pathogen detection with decision support for physicians and medical laboratories.
Explore Noscendo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.